• Publications
  • Influence
A Randomized, Double-Blind, Placebo-Controlled Dose Range Study of Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal*
Objectives:To evaluate dexmedetomidine as adjunctive therapy to lorazepam for severe alcohol withdrawal. Design:Prospective, randomized, double-blind, placebo-controlled trial. Setting:Single center;Expand
  • 69
  • 7
Pharmacist contributions as members of the multidisciplinary ICU team.
Critical care pharmacy services in the ICU have expanded from traditional dispensing responsibilities to being recognized as an essential component of multidisciplinary care for critically illExpand
  • 75
  • 2
A Randomized, Double-Blind Pilot Study of Dexmedetomidine Versus Midazolam for Intensive Care Unit Sedation
Introduction: Sedation with dexmedetomidine may facilitate ventilator liberation and limit the occurrence of delirium. No trial has assessed patient recall or the development of psychologicalExpand
  • 20
  • 1
A survey of prescriber perceptions about the prevention of stress-related mucosal bleeding in the intensive care unit.
WHAT IS KNOWN AND OBJECTIVE Practices vary between institutions and amongst prescribers regarding when to initiate stress ulcer prophylaxis (SUP), which agent to choose (including doses andExpand
  • 15
A double-blind, randomized controlled trial of gabapentin vs. placebo for acute pain management in critically ill patients with rib fractures.
INTRODUCTION Achieving adequate pain control for rib fractures remains challenging; prescription of alternatives to narcotics is imperative to curtail the current opioid epidemic. Although gabapentinExpand
  • 10
Stability of dexmedetomidine in polyvinyl chloride bags containing 0.9% sodium chloride injection.
PURPOSE The stability of dexmedetomidine in polyvinyl chloride (PVC) bags containing 0.9% sodium chloride injection was studied. METHODS Dexmedetomidine solutions (4, 8, 12, and 20 μg/mL; n = 6 forExpand
  • 4
Tenecteplase utility in acute ischemic stroke patients: A clinical review of current evidence
Introduction: Acute ischemic stroke is a leading cause of disability in the United States. Treatment is aimed at reducing impact of cerebral clot burden and life‐long disability. TraditionalExpand